We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.SELEXIS COMMERCIAL LICENSE AGREEMENT ENTERED INTO WITH BIOGENERICS, INC.Commercial License Agreement • September 25th, 2014 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledSeptember 25th, 2014 Company Industry JurisdictionThis Commercial License Agreement (the “Agreement”) is made effective on April 8, 2011 (the “Effective Date”), by and between SELEXIS SA, 18 chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland SA (“Selexis”) and BIOGENERICS, INC. 555 Bryant Street, Ste 266, Palo Alto, CA 94301 (“COMPANY”).
COMMERCIAL LICENSE AGREEMENT ENTERED INTO WITH COHERUS BIOSCIENCES, INC.Commercial License Agreement • September 25th, 2014 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledSeptember 25th, 2014 Company Industry JurisdictionThis Commercial License Agreement (the “Agreement”) is made effective on as of June 25, 2012 (the “Effective Date”), by and between SELEXIS SA, 18 chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland SA (“Selexis”) and COHERUS BIOSCIENCES, INC., 201 Redwood Shores Parkway, Suite 200, Redwood City, CA 94065 (“COMPANY”).
SELEXIS COMMERCIAL LICENSE AGREEMENT ENTERED INTO WITH BIOGENERICS, INC.Commercial License Agreement • August 5th, 2014 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 5th, 2014 Company Industry JurisdictionThis Commercial License Agreement (the “Agreement”) is made effective on April 8, 2011 (the “Effective Date”), by and between SELEXIS SA, 18 chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland SA (“Selexis”) and BIOGENERICS, INC. 555 Bryant Street, Ste 266, Palo Alto, CA 94301 (“COMPANY”).
COMMERCIAL LICENSE AGREEMENT ENTERED INTO WITH COHERUS BIOSCIENCES, INC.Commercial License Agreement • August 5th, 2014 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 5th, 2014 Company Industry JurisdictionThis Commercial License Agreement (the “Agreement”) is made effective on as of June 25, 2012 (the “Effective Date”), by and between SELEXIS SA, 18 chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland SA (“Selexis”) and COHERUS BIOSCIENCES, INC., 201 Redwood Shores Parkway, Suite 200, Redwood City, CA 94065 (“COMPANY”).